KILITCH
Kilitch Drugs (India) Limited
Pharmaceuticals · ₹643 Cr market cap
A pharmaceutical manufacturer engaged in the production and distribution of generic drugs and pharmaceutical formulations across India. Incorporated in 1978, Kilitch Drugs operates across multiple therapeutic segments including cardiovascular, gastrointestinal, respiratory, and anti-infective treatments. The company serves hospitals, clinics, and retail pharmacy channels through its established distribution infrastructure, catering to both domestic markets and institutional healthcare providers.
2
Tracked investors holding
1
Tracked moves
₹184
Share price
Latest activity
Dipak Kanayalal ShahDecreased
Dipak Kanayalal Shah decreased his stake in Kilitch Drugs (India) from 3.64% to 3.20% by selling 1,52,500 shares. The sale was valued at ₹2.79 crore, with shares transacting at ₹183.12 apiece.
Top investors holding Kilitch Drugs (India) Limited
3.20%
1.34%
Track smart money in Kilitch Drugs (India) Limited
Get alerted when a top investor buys or sells.
Get started